Annual EBITDA:
-$26.62M-$27.80M(-2351.78%)Summary
- As of today, AQST annual EBITDA is -$26.62 million, with the most recent change of -$27.80 million (-2351.78%) on December 31, 2024.
- During the last 3 years, AQST annual EBITDA has risen by +$18.50 million (+41.00%).
- AQST annual EBITDA is now -1137.66% below its all-time high of $2.56 million, reached on December 31, 2017.
Performance
AQST EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$11.34M-$112.00K(-1.00%)Summary
- As of today, AQST quarterly EBITDA is -$11.34 million, with the most recent change of -$112.00 thousand (-1.00%) on September 30, 2025.
- Over the past year, AQST quarterly EBITDA has dropped by -$3.21 million (-39.47%).
- AQST quarterly EBITDA is now -199.57% below its all-time high of $11.39 million, reached on September 30, 2017.
Performance
AQST Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$55.23M-$3.21M(-6.17%)Summary
- As of today, AQST TTM EBITDA is -$55.23 million, with the most recent change of -$3.21 million (-6.17%) on September 30, 2025.
- Over the past year, AQST TTM EBITDA has dropped by -$35.16 million (-175.24%).
- AQST TTM EBITDA is now -521.64% below its all-time high of $13.10 million, reached on September 30, 2017.
Performance
AQST TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AQST EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -2351.8% | -39.5% | -175.2% |
| 3Y3 Years | +41.0% | -37.3% | -37.0% |
| 5Y5 Years | +50.7% | +13.1% | -62.1% |
AQST EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -2351.8% | +41.0% | -4461.5% | +41.0% | -301.2% | at low |
| 5Y | 5-Year | -2351.8% | +50.7% | -4461.5% | +41.0% | -301.2% | at low |
| All-Time | All-Time | -1137.7% | +50.7% | -199.6% | +64.5% | -521.6% | +14.0% |
AQST EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$11.34M(-1.0%) | -$55.23M(-6.2%) |
| Jun 2025 | - | -$11.23M(+41.6%) | -$52.02M(-28.3%) |
| Mar 2025 | - | -$19.23M(-43.1%) | -$40.53M(-34.9%) |
| Dec 2024 | -$26.62M(-2351.8%) | -$13.43M(-65.2%) | -$30.05M(-49.8%) |
| Sep 2024 | - | -$8.13M(-3227.3%) | -$20.07M(-42.8%) |
| Jun 2024 | - | $260.00K(+103.0%) | -$14.05M(+22.9%) |
| Mar 2024 | - | -$8.75M(-154.1%) | -$18.23M(-32.5%) |
| Dec 2023 | $1.18M(+103.0%) | -$3.44M(-62.5%) | -$13.76M(+33.3%) |
| Sep 2023 | - | -$2.12M(+45.9%) | -$20.64M(+22.9%) |
| Jun 2023 | - | -$3.92M(+8.4%) | -$26.77M(+23.4%) |
| Mar 2023 | - | -$4.28M(+58.5%) | -$34.95M(+11.9%) |
| Dec 2022 | -$39.58M(+12.3%) | -$10.32M(-24.9%) | -$39.68M(+1.5%) |
| Sep 2022 | - | -$8.26M(+31.7%) | -$40.30M(-2.6%) |
| Jun 2022 | - | -$12.10M(-34.2%) | -$39.27M(-19.2%) |
| Mar 2022 | - | -$9.01M(+17.6%) | -$32.96M(-3.9%) |
| Dec 2021 | -$45.11M | -$10.94M(-51.3%) | -$31.71M(+9.8%) |
| Sep 2021 | - | -$7.23M(-25.2%) | -$35.15M(+14.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$5.78M(+25.6%) | -$40.97M(-20.2%) |
| Mar 2021 | - | -$7.77M(+45.9%) | -$34.08M(+13.2%) |
| Dec 2020 | -$39.32M(+27.2%) | -$14.37M(-10.1%) | -$39.29M(-15.3%) |
| Sep 2020 | - | -$13.05M(-1279.2%) | -$34.06M(-8.9%) |
| Jun 2020 | - | $1.11M(+108.5%) | -$31.27M(+37.8%) |
| Mar 2020 | - | -$12.97M(-41.9%) | -$50.30M(-1.4%) |
| Dec 2019 | -$54.02M(-7.1%) | -$9.14M(+10.9%) | -$49.62M(+4.7%) |
| Sep 2019 | - | -$10.26M(+42.8%) | -$52.07M(-3.6%) |
| Jun 2019 | - | -$17.93M(-45.9%) | -$50.27M(+21.8%) |
| Mar 2019 | - | -$12.29M(-6.1%) | -$64.25M(-40.6%) |
| Dec 2018 | -$50.43M(-2066.0%) | -$11.59M(-37.0%) | -$45.70M(-13.1%) |
| Sep 2018 | - | -$8.46M(+73.5%) | -$40.40M(-96.6%) |
| Jun 2018 | - | -$31.91M(-609.9%) | -$20.55M(-280.9%) |
| Mar 2018 | - | $6.26M(+199.5%) | $11.36M(+66.8%) |
| Dec 2017 | $2.56M(+493.8%) | -$6.29M(-155.2%) | $6.81M(-48.0%) |
| Sep 2017 | - | $11.39M(+566.4%) | $13.10M(+666.4%) |
| Mar 2017 | - | $1.71M | $1.71M |
| Dec 2016 | $432.00K | - | - |
FAQ
- What is Aquestive Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Aquestive Therapeutics, Inc.?
- What is Aquestive Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Aquestive Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Aquestive Therapeutics, Inc.?
- What is Aquestive Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Aquestive Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Aquestive Therapeutics, Inc.?
- What is Aquestive Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Aquestive Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of AQST is -$26.62M
What is the all-time high annual EBITDA for Aquestive Therapeutics, Inc.?
Aquestive Therapeutics, Inc. all-time high annual EBITDA is $2.56M
What is Aquestive Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, AQST annual EBITDA has changed by -$27.80M (-2351.78%)
What is Aquestive Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of AQST is -$11.34M
What is the all-time high quarterly EBITDA for Aquestive Therapeutics, Inc.?
Aquestive Therapeutics, Inc. all-time high quarterly EBITDA is $11.39M
What is Aquestive Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, AQST quarterly EBITDA has changed by -$3.21M (-39.47%)
What is Aquestive Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of AQST is -$55.23M
What is the all-time high TTM EBITDA for Aquestive Therapeutics, Inc.?
Aquestive Therapeutics, Inc. all-time high TTM EBITDA is $13.10M
What is Aquestive Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, AQST TTM EBITDA has changed by -$35.16M (-175.24%)